The effect of serum protein fractions on liposome-cell interactions in cultured cells and the perfused rat liver.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 857912)

Published in Biochim Biophys Acta on April 27, 1977

Authors

D A Tyrrell, V J Richardson, B E Ryman

Articles by these authors

The fate of certain organic acids and amides in the rabbit: 2. p-Hydroxybenzoic acid and its amide. Biochem J (1947) 10.50

Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 9.26

Psychological stress and susceptibility to the common cold. N Engl J Med (1991) 6.84

The fate of certain organic acids and amides in the rabbit: 3. Hydrolysis of amides by enzymes in vitro. Biochem J (1948) 5.12

The fate of certain organic acids and amides in the rabbit. 5. o- and m-hydroxybenzoic acids and amides. Biochem J (1948) 4.87

A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1968) 4.66

Experimental parvoviral infection in humans. J Infect Dis (1985) 4.62

Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31

Trials of Live Influenza Vaccine in the Royal Air Force. Br Med J (1962) 4.06

Inhibition of haemaggregation by lepromin and other mycobacterial substances. Nature (1967) 3.84

Work of a district ethical committee. Br Med J (1979) 3.64

The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect (1990) 3.12

The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10

Inhibition of respiratory virus infection by locally applied interferon. Lancet (1973) 3.02

Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01

Role of viruses in febrile convulsions. Arch Dis Child (1979) 2.72

Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70

Investigetion into the attenuation of influenza viruses by serial passage. Br Med J (1968) 2.67

Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers. Lancet (1975) 2.61

Antiviral activity in milk of possible clinical importance. Lancet (1976) 2.47

Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha. J Hyg (Lond) (1967) 2.42

Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2-Hong Kong-68 (H 3 N 2 ) influenza vaccines. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines. J Hyg (Lond) (1972) 2.40

A new virus cultivated only in organ cultures of human ciliated epithelium. Arch Gesamte Virusforsch (1966) 2.34

Common colds on Tristan da Cunha. J Hyg (Lond) (1971) 2.34

New aspects of liposomes. Biochim Biophys Acta (1976) 2.27

A virus from epidemic vomiting disease. Br Med J (1972) 2.26

The fate of certain organic acids and amides in the rabbit. 7. An amidase of rabbit liver. Biochem J (1949) 2.26

Organ cultures in virology. Prog Med Virol (1969) 2.21

Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol (1980) 2.21

Improvements in a method of growing respiratory viruses in organ cultures. Br J Exp Pathol (1967) 2.13

Some improved techniques for the study of rhinoviruses using HeLa cells. Arch Gesamte Virusforsch (1968) 2.13

Coronaviridae: second report. Intervirology (1978) 2.05

The growth of some myxoviruses in organ cultures. Br J Exp Pathol (1965) 2.05

Cultivation of viruses from a high proportion of patients with colds. Lancet (1966) 2.04

Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines. J Hyg (Lond) (1969) 2.02

Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol (1993) 1.99

Effects of a "new" human respiratory virus in volunteers. Br Med J (1967) 1.98

Lysosomal localization of -fructofuranosidase-containing liposomes injected into rats. Biochem J (1972) 1.97

Trial of ascorbic acid in prevention of colds. Br Med J (1967) 1.90

A year's experience of the rotavirus syndrome and its association with respiratory illness. Arch Dis Child (1979) 1.85

Experiments on the spread of colds. II. Studies in volunteers with coxsackievirus A21. J Hyg (Lond) (1965) 1.82

A comparative study of attenuated influenza viruses. Bull World Health Organ (1971) 1.81

An investigation of media for the long term storage of three respiratory viruses. Arch Gesamte Virusforsch (1974) 1.78

Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases. Eur J Biochem (1972) 1.74

Toxicity of interferon. Br Med J (Clin Res Ed) (1981) 1.69

The activity of enviroxime against rhinovirus infection in man. Lancet (1981) 1.66

Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli. Lancet (1982) 1.66

Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines. J Hyg (Lond) (1977) 1.62

Further trials of live influenza vaccine. Br Med J (1966) 1.58

The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture. J Gen Virol (1967) 1.58

Cultivation of "difficult" viruses from patients with common colds. Br Med J (1968) 1.57

Electron microscopic observations on the entry of influenza virus into susceptible cells. J Gen Virol (1974) 1.55

Coronaviridae. Intervirology (1975) 1.55

Growth of viruses in organ cultures of intestine. Br J Exp Pathol (1970) 1.54

A mathematical model of common-cold epidemics on Tristan da Cunha. J Hyg (Lond) (1971) 1.47

Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J Biol Stand (1979) 1.45

Outcome of Medicare patients with emphysema selected for, but denied, a lung volume reduction operation. Ann Thorac Surg (1998) 1.45

Smoking, alcohol consumption, and susceptibility to the common cold. Am J Public Health (1993) 1.43

Sendai virus infection of rats as a convenient model of acute respiratory infection. Vet Rec (1970) 1.42

Live influenza vaccines. Lancet (1983) 1.39

The radiation dosimetry of 99Tcm-exametazime. Nucl Med Commun (1990) 1.39

Prophylaxis of influenza with a synthetic isoquinoline. Lancet (1968) 1.38

Picornaviridae. Intervirology (1974) 1.36

The action pattern of amylomaltase from Escherichia coli. Eur J Biochem (1976) 1.35

Failure of oral 4',6-dichloroflavan to protect against rhinovirus infection in man. Arch Virol (1983) 1.35

New aspects of glycogen metabolism. Adv Enzymol Relat Areas Mol Biol (1971) 1.33

Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837). Antimicrob Agents Chemother (1989) 1.33

Tissue distribution and tumour localization of 99m-technetium-labelled liposomes in cancer patients. Br J Cancer (1979) 1.32

The adjuvant properties of liposomes. Biochem Soc Trans (1976) 1.30

Antibody responses to and efficacy of an inactivated spray vaccine. Bull World Health Organ (1969) 1.29

Deficient production of leucocyte interferon (interferon-alpha) in vitro and in vivo in children with recurrent respiratory tract infections. Lancet (1981) 1.27

Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother (1987) 1.27

Titration of tuberculin, nucleic acids and viruses by haemaggregation inhibition using a "pattern" test. Br J Exp Pathol (1967) 1.26

Liposome toxicity in the mouse central nervous system. J Neurol Sci (1977) 1.26

Contracture of phosphorylase deficient muscle. J Neurol Neurosurg Psychiatry (1968) 1.26

An epidemic of influenza on Tristan da Cunha. J Hyg (Lond) (1973) 1.26

Identification of rhinovirus stran D.C. Nature (1968) 1.24

Upper respiratory tract viral infection and mucociliary clearance. Eur J Respir Dis (1987) 1.23

Skin tests with influenza virus. J Hyg (Lond) (1973) 1.22

Viruses in febrile convulsions. Lancet (1980) 1.22

Possible virus in schizophrenia and some neurological disorders. Lancet (1979) 1.21

Purified interferon as protection against rhinovirus infection. Br Med J (Clin Res Ed) (1982) 1.21

Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J Gen Virol (2001) 1.19

Echovirus encephalitis and myositis in primary immunoglobulin deficiency. Arch Dis Child (1978) 1.18

Drug resistant rhinoviruses from the nose of experimentally treated volunteers. Arch Virol (1989) 1.18

Interferon: therapeutic fact or fiction for the '80s? Br Med J (1980) 1.18

A cytotoxic factor in cholera toxin. Br J Exp Pathol (1970) 1.16

Arthritis after meningococcal meningitis. Br Med J (1977) 1.16

Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J Nucl Med (1986) 1.16

Studies on the antiviral activity of 1-adamantanamine. Br J Exp Pathol (1965) 1.16

Liposomally entrapped second antibody improves tumour imaging with radiolabelled (first) antitumour antibody. Lancet (1982) 1.15

Some inhibitors of the effect of cholera toxin on HeLa cells. Exp Mol Pathol (1973) 1.12

Prophylactic intranasal alpha 2 interferon and viral exacerbations of chronic respiratory disease. Thorax (1991) 1.11

The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes. Biochim Biophys Acta (1981) 1.10

A 'new' generation of more potent synthetic antirhinovirus compounds: comparison of their MICs and their synergistic interactions. Antiviral Res (1987) 1.09

The propagation of "coronaviruses" in tissue-culture. Arch Gesamte Virusforsch (1969) 1.08

Vaccination against Hong Kong influenza in Britain, 1968-9. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines. J Hyg (Lond) (1970) 1.08